Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors.
Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors. — المؤلف: Loganathan, Sudan N — Molecular cancer therapeutics 20200323
- المؤلف
- Loganathan, Sudan N
- النشر
- Molecular cancer therapeutics 20200323
- الوصف
- 929-936 p.
- الموضوعات
- Animals؛ Antineoplastic Combined Chemotherapy Protocols؛ Apoptosis؛ Cell Cycle Proteins؛ Cell Line, Tumor؛ Cell Proliferation؛ Gene Expression Regulation, Neoplastic؛ Heterografts